Radiation Oncologist - HS Clinical Professor, In Residence, and Clinical X Series (Irvine)
Open date: April 10, 2023
Most recent review date: Monday, Apr 10, 2023 at 11:59pm (Pacific Time)
Applications received after this date will be reviewed by the search committee if the position has not yet been filled.
Final date: Tuesday, Mar 19, 2024 at 11:59pm (Pacific Time)
Applications will continue to be accepted until this date, but those received after the review date will only be considered if the position has not yet been filled.
The Department of Radiation Oncology at the University of California, Irvine -School of Medicine invites applications for the position of Radiation Oncologist for all ranks in the HS Clinical Professor Series, In-Residence Series, and all ranks in the Professor of Clinical "X" Series (Assistant, Associate, In-Residence, and/or Full Professor levels). Duties will include clinical care, teaching of residents and students, and scholarly activity. Priority will be given to candidates with a proven track record of academic productivity, as demonstrated through high-impact publications and/or grant funding. Skills conducive to practice-building will be especially valued, as well as an ability to work collaboratively within and outside of the Department.
Applicants must possess an M.D. degree (or equivalent), be board certified in Radiation Oncology (or eligible by time of appointment) and hold an unrestricted CA medical license (by time of appointment).
Salary commensurate with experience and qualifications.
Criteria for the Professor of Clinical "X" Series: The incumbent will be expected to conduct substantial research; provide patient care; teach fellows, residents, and medical students; and perform public and University service. Excellent teaching is an essential criteria for appointment in this series.
Criteria for the Health Sciences Clinical Professor Series: The incumbent will be expected to teach fellows, residents, and medical students; provide patient care; contribute to scholarly activities; and provide public and University service.
Criteria for the In-Residence Professor Series: The incumbent will be expected to develop an independent translational research program in neuroscience, cancer, and/or radiation biology. Research skills and interests should include but are not restricted to the study of radiation and/or chemotherapy effects in the intact CNS and on the development of multipronged strategies for ameliorating normal tissue injury following cytotoxic cancer treatments. Highly desirable in experience in basic radiation sciences, cancer/stem cell biology, cognitive testing, and in particular, the micromorphometric and immunohistochemical analysis of neuronal structure and synaptic integrity. The incumbent will also be expected to develop an independent line of investigation and to fund the majority of these research activities through extramural funding. To facilitate these efforts, protected research time and start-up funds will be provided. The successful candidate will be expected to participate in the teaching curriculum for the radiation oncology residents.
Located at the University of California, Irvine Cancer Center in Irvine, California, the Department of Radiation Oncology is an integral part of the NCI-designated Chao Family Comprehensive Cancer Center. The Department is equipped with a robust blend of technology, including a dedicated HDR brachytherapy suite and an intraoperative unit. Further equipment upgrades are planned. The Department features a four-year Radiation Oncology residency training program and a Medical Physics training program. The Department has an active Radiation Biology Division that currently ranks among the top programs in the nation with respect to NIH funding. The Department participates in NRG/RTOG and SWOG and encourages investigator-initiated clinical and translational trials.
Founded in 1965, the University of California, Irvine is the youngest member of the prestigious Association of American Universities. The campus has produced 3 Nobel laureates and is known for its academic achievement, premier research, innovation, and anteater mascot. The University has more than 36,000 students and offers 222-degree programs. It is located in one of the world's safest and most economically vibrant communities and is Orange County's second largest employer. The "OC" offers a multitude of recreational and cultural opportunities and is home to Disneyland, as well as to the beach enclaves of Laguna Beach, Newport Beach, and Huntington Beach ("Surf City USA").
Applicants must complete an online application profile and upload the following applications materials electronically to be considered for the position:
• Curriculum vitae
• Cover letter
• Statement of Teaching
• Names and addresses of three references
• Statement of contributions to diversity
Applicants must possess an M.D. degree (or equivalent), be board certified in radiation Oncology (or eligible by time of appointment) and hold an unrestricted CA medical license (by time of appointment).
Curriculum Vitae - Your most recently updated C.V.
Statement of Research (Optional)
Teaching Statement - See our guidance for writing a reflective teaching statement.
Inclusive Excellence Activities Statement - Statement addressing how past and/or potential contributions to inclusive excellence will advance UCI's Commitment to Inclusive Excellence. See our guidance for writing an inclusive excellence activities statement.
Misc / Additional (Optional)
- 3-5 letters of reference required
The University of California, Irvine is an Equal Opportunity/Affirmative Action Employer advancing inclusive excellence. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, age, protected veteran status, or other protected categories covered by the UC nondiscrimination policy.
As a condition of employment, you will be required to comply with the University of California Policy on Vaccination Programs – With Updated Interim Amendments. All Covered Individuals under the policy must provide proof of receiving the COVID-19 Vaccine Primary Series or, if applicable, submit a request for Exception (based on Medical Exemption, Disability, Religious Objection, and/or Deferral based on pregnancy or recent COVID-19 diagnosis and/or treatment) no later than the applicable deadline. All Covered Individuals must also provide proof of receiving the most recent CDC-recommended COVID-19 booster or properly decline such booster no later than the applicable deadline. New University of California employees should refer to Exhibit 2, Section II.C. of the SARS-CoV-2 (COVID-19) Vaccination Program Attachment for applicable deadlines. All Covered Individuals must also provide proof of being up-to-date on seasonal influenza vaccination or properly decline such vaccination no later than the applicable deadline. Please refer to the Seasonal Influenza Vaccination Program Attachment. (Capitalized terms in this paragraph are defined in the policy.) Federal, state, or local public health directives may impose additional requirements.